CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Accordingly, ESRD patients are particularly susceptible to COVID-19 infection. Ta1 has been shown to be safely administered to hemo...
Phase 2
Kansas City, Missouri, United States of America
multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and moderate symptoms of COVID...
Phase 2
Kansas City, Kansas, United States and 6 other locations
multi-center clinical trial (RCT) of SPI-1005 in adult subjects with positive PCR test for novel SARS-CoV-2 (nCoV2) and severe symptoms of COVID...
Phase 2
Kansas City, Kansas, United States and 6 other locations
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
Kansas City, Missouri, United States and 217 other locations
(SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID...
Phase 2
Kansas City, Missouri, United States and 144 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Fairway, Kansas, United States and 66 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Kansas City, Missouri, United States and 31 other locations
against infection with SARS-CoV-2, the novel coronavirus causing COVID-19 disease. The investigational vaccine, MV-014-212, is a li...
Phase 1
Lenexa, Kentucky, United States of America and 1 other location
This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
Phase 3
Overland Park, Kansas, United States and 73 other locations
This study will evaluate the reactogenicity, safety, and immune response of Flu Seasonal/SARS-CoV-2 mRNA (mRNA Flu/COVID-19) combin-...
Phase 1, Phase 2
Lenexa, Kansas, United States and 8 other locations
Clinical trials
Research sites
Resources
Legal